Novel DNA binding domain-based assays for detection of methylated and nonmethylated DNA

Epigenomics

Volumn 3, Issue 1, 2011, Pages 93-101

  Acevedo, Luis G ^a   Sanz, Ana ^a   Jelinek, Mary Anne ^b  

^a Active Motif Inc   (United States)

^b Active Motif Inc   (United States)

Author keywords

CXXC; DNA methylation; hydroxymethyl cytidine; MBD; methyl CpG binding domains; methyl cytidine; nonmethyl CpG binding domains

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; 5 METHYLCYTOSINE; DNA; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3A;

ARTICLE; CPG ISLAND; DNA BINDING; DNA DETERMINATION; DNA METHYLATION; DNA MICROARRAY; DNA SEQUENCE; EPIGENETICS; GENE LOCUS; HUMAN; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN DOMAIN;

5-METHYLCYTOSINE; BIOLOGICAL MARKERS; CPG ISLANDS; CYTOSINE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA PRIMERS; HUMANS; IMMUNOPRECIPITATION; POLYMERASE CHAIN REACTION; PROTEIN INTERACTION DOMAINS AND MOTIFS; SENSITIVITY AND SPECIFICITY; SULFITES;

EUKARYOTA;

EID: 79951923156     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.10.69     Document Type: Article

References (77)

1. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 321(6067), 209-213 (1986). (Pubitemid 16016411)
2. Henikoff S, Matzke MA: Exploring and explaining epigenetic effects. Trends Genet. 13(8), 293-295 (1997).
3. Wolffe AP, Matzke MA: Epigenetics: regulation through repression. Science 286(5439), 481-486 (1999).
4. Reik W, Dean W, Walter J: Epigenetic reprogramming in mammalian development. Science 293(5532), 1089-1093 (2001). (Pubitemid 32758081)
5. Grewal SI, Moazed D: Heterochromatin and epigenetic control of gene expression. Science 301(5634), 798-802 (2003). (Pubitemid 36962612)
6. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3(6), 415-428 (2002). (Pubitemid 34587077)
7. Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res. 61(8), 3225-3229 (2001). (Pubitemid 32695003)
8. Plazas-Mayorca MD, Vrana KE: Proteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior? J. Proteome Res. 10(1), 58-65 (2010).
9. Esteller M: Dormant hypermethylated tumour suppressor genes: questions and answers. J. Pathol. 205(2), 172-180 (2005). (Pubitemid 40227989)
10. Kalebic T: Epigenetic changes: potential therapeutic targets. Ann. NY Acad. Sci. 983, 278-285 (2003). (Pubitemid 36399340)
11. Frommer M, Mcdonald LE, Millar DS et al.: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA 89(5), 1827-1831 (1992).
12. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA 93(18), 9821-9826 (1996). (Pubitemid 26296693)
13. Eads CA, Danenberg KD, Kawakami K et al.: Methylight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28(8), E32 (2000).
14. Dahl C, Guldberg P: DNA methylation analysis techniques. Biogerontology 4(4), 233-250 (2003). (Pubitemid 37098463)
15. Irizarry RA, Ladd-Acosta C, Carvalho B et al.: Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res. 18(5), 780-790 (2008). (Pubitemid 351645068)
16. Weber M, Davies JJ, Wittig D et al.: Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37(8), 853-862 (2005). (Pubitemid 41077111)
17. Acevedo LG, Bieda M, Green R, Farnham PJ: Analysis of the mechanisms mediating tumor-specific changes in gene expression in human liver tumors. Cancer Res. 68(8), 2641-2651 (2008). (Pubitemid 351556261)
18. Cross SH, Charlton JA, Nan X, Bird AP: Purification of CpG islands using a methylated DNA binding column. Nat. Genet. 6(3), 236-244 (1994). (Pubitemid 24188619)
19. Klose RJ, Sarraf SA, Schmiedeberg L, Mcdermott SM, Stancheva I, Bird AP: DNA binding selectivity of MECP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell 19(5), 667-678 (2005). (Pubitemid 41219442)
20. Gebhard C, Schwarzfischer L, Pham TH, Andreesen R, Mackensen A, Rehli M: Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR. Nucleic Acids Res. 34(11), e82 (2006).
21. Laird PW: Principles and challenges of genome-wide DNA methylation analysis. Nat. Rev. Genet. 11(3), 191-203 (2010).
22. Bock C, Tomazou EM, Brinkman AB et al.: Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat. Biotechnol. 28(10), 1106-1114 (2010).
23. Harris RA, Wang T, Coarfa C et al.: Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat. Biotechnol. 28(10), 1097-1105 (2010).
24. Li N, Ye M, Li Y et al.: Whole genome DNA methylation analysis based on high throughput sequencing technology. Methods 28(10), 1106-1114 (2010).
25. Lister R, Ecker JR: Finding the fifth base: Genome-wide sequencing of cytosine methylation. Genome Res. 19(6), 959-966 (2009).
26. Nair SS, Coolen MW, Stirzaker C et al.: Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics 6(1), (2011) (Epub ahead of print).
27. Hendrich B, Bird A: Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell Biol. 18(11), 6538-6547 (1998). (Pubitemid 28500543)
28. Hashimoto H, Horton JR, Zhang X, Cheng X: Uhrf1, a modular multi-domain protein, regulates replication-coupled crosstalk between DNA methylation and histone modifications. Epigenetics 4(1), 8-14 (2009).
29. Filion GJ, Zhenilo S, Salozhin S, Yamada D, Prokhortchouk E, Defossez PA: A family of human zinc finger proteins that bind methylated DNA and repress transcription. Mol. Cell Biol. 26(1), 169-181 (2006).
30. Prokhortchouk A, Hendrich B, Jorgensen H et al.: The p120 catenin partner kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev. 15(13), 1613-1618 (2001). (Pubitemid 32702582)
31. Yoon HG, Chan DW, Reynolds AB, Qin J, Wong J: N-cor mediates DNA methylation-dependent repression through a methyl CpG binding protein kaiso. Mol. Cell 12(3), 723-734 (2003). (Pubitemid 37222492)
32. Lopes EC, Valls E, Figueroa ME et al.: Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines. Cancer Res. 68(18), 7258-7263 (2008).
33. Weber A, Marquardt J, Elzi D et al.: Zbtb4 represses transcription of p21cip1 and controls the cellular response to p53 activation. EMBO J. 27(11), 1563-1574 (2008). (Pubitemid 351794031)
34. Daniel JM, Spring CM, Crawford HC, Reynolds AB, Baig A: The p120(ctn)-binding partner kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res. 30(13), 2911-2919 (2002). (Pubitemid 34778152)
35. Sasai N, Nakao M, Defossez PA: Sequence-specific recognition of methylated DNA by human zinc-finger proteins. Nucleic Acids Res. 38(15), 5015-5022 (2010).
36. Gebhard C, Schwarzfischer L, Pham TH et al.: Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res. 66(12), 6118-6128 (2006).
37. Down TA, Rakyan VK, Turner DJ et al.: A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat. Biotechnol. 26(7), 779-785 (2008). (Pubitemid 351961453)
38. Rauch T, Pfeifer GP: Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer. Lab. Invest. 85(9), 1172-1180 (2005). (Pubitemid 43073989)
39. Kimura H, Hayashi-Takanaka Y, Yamagata K: Visualization of DNA methylation and histone modifications in living cells. Curr. Opin. Cell Biol. 22(3), 412-418 (2010).
40. Yamagata K, Yamazaki T, Miki H et al.: Centromeric DNA hypomethylation as an epigenetic signature discriminates between germ and somatic cell lineages. Dev. Biol. 312(1), 419-426 (2007). (Pubitemid 350180767)
41. Kimura N, Moribe T, Iizuka N et al.: Rapid and quantitative detection of CpG-methylation status using Taqman PCR combined with methyl-binding-domain polypeptide. Clin. Biochem. 42(10-11), 1113-1122 (2009).
42. Luo J, Zheng W, Wang Y, Wu Z, Bai Y, Lu Z: Detection method for methylation density on microarray using methyl-CpG-binding domain protein. Anal. Biochem. 387(2), 143-149 (2009).
43. Wilson AS, Power BE, Molloy PL: DNA hypomethylation and human diseases. Biochim. Biophys. Acta. 1775(1), 138-162 (2007). (Pubitemid 44881198)
44. Paredes J, Albergaria A, Oliveira JT, Jeronimo C, Milanezi F, Schmitt FC: P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin. Cancer Res. 11(16), 5869-5877 (2005). (Pubitemid 41170315)
45. Liu H, Liu W, Wu Y et al.: Loss of epigenetic control of synuclein-g gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res. 65(17), 7635-7643 (2005). (Pubitemid 41297236)
46. Woodson K, Mason J, Choi SW et al.: Hypomethylation of p53 in peripheral blood DNA is associated with the development of lung cancer. Cancer Epidemiol. Biomarkers Prev. 10(1), 69-74 (2001). (Pubitemid 32106047)
47. Callinan PA, Feinberg AP: The emerging science of epigenomics. Hum. Mol. Genet. 15(Spec. No. 1), R95-R101 (2006).
48. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP: A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res. 32(3), e38 (2004).
49. Ogino S, Nosho K, Kirkner GJ et al.: A cohort study of tumoral line-1 hypomethylation and prognosis in colon cancer. J. Natl Cancer Inst. 100(23), 1734-1738 (2008).
50. Irahara N, Nosho K, Baba Y et al.: Precision of pyrosequencing assay to measure line-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. J. Mol. Diagn. 12(2), 177-183 (2010).
51. Cheng X, Blumenthal RM: Mammalian DNA methyltransferases: a structural perspective. Structure 16(3), 341-350 (2008). (Pubitemid 351324115)
52. Chen T, Li E: Establishment and maintenance of DNA methylation patterns in mammals. Curr. Top. Microbiol. Immunol. 301, 179-201 (2006). (Pubitemid 43022672)
53. Mortusewicz O, Schermelleh L, Walter J, Cardoso MC, Leonhardt H: Recruitment of DNA methyltransferase I to DNA repair sites. Proc. Natl Acad. Sci. USA 102(25), 8905-8909 (2005). (Pubitemid 40881051)
54. Ooi SK, Bestor TH: Cytosine methylation: remaining faithful. Curr. Biol. 18(4), R174-R176 (2008). (Pubitemid 351258345)
55. Voo KS, Carlone DL, Jacobsen BM, Flodin A, Skalnik DG: Cloning of a mammalian transcriptional activator that binds unmethylated CpG motifs and shares a CXXC domain with DNA methyltransferase, human trithorax, and methyl-CpG binding domain protein 1. Mol. Cell Biol. 20(6), 2108-2121 (2000). (Pubitemid 30123826)
56. Cross SH, Meehan RR, Nan X, Bird A: A component of the transcriptional repressor MECP1 shares a motif with DNA methyltransferase and HRX proteins. Nat. Genet. 16(3), 256-259 (1997).
57. Jorgensen HF, Ben-Porath I, Bird AP: Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains. Mol. Cell Biol. 24(8), 3387-3395 (2004). (Pubitemid 38452081)
58. Ma Q, Alder H, Nelson KK et al.: Analysis of the murine ALL-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases. Proc. Natl Acad. Sci. USA 90(13), 6350-6354 (1993). (Pubitemid 23191513)
59. Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H, Hayashi Y: LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11) (q22;q23). Cancer Res. 62(14), 4075-4080 (2002). (Pubitemid 34791077)
60. Hughes CM, Rozenblatt-Rosen O, Milne TA et al.: Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol. Cell 13(4), 587-597 (2004). (Pubitemid 38299385)
61. Fitzgerald KT, Diaz MO: MlL2: a new mammalian member of the TRX/MLL family of genes. Genomics 59(2), 187-192 (1999). (Pubitemid 29365349)
62. Tsukada Y, Fang J, Erdjument-Bromage H et al.: Histone demethylation by a family of JMJC domain-containing proteins. Nature 439(7078), 811-816 (2006). (Pubitemid 43255695)
63. Blackledge NP, Zhou JC, Tolstorukov MY, Farcas AM, Park PJ, Klose RJ: CpG islands recruit a histone H3 lysine 36 demethylase. Mol. Cell 38(2), 179-190 (2010).
64. Thomson JP, Skene PJ, Selfridge J et al.: CpG islands influence chromatin structure via the CpG-binding protein CFP1. Nature 464(7291), 1082-1086 (2010).
65. Okada Y, Yamagata K, Hong K, Wakayama T, Zhang Y: A role for the elongator complex in zygotic paternal genome demethylation. Nature 463(7280), 554-558 (2010).
66. Illingworth R, Kerr A, Desousa D et al.: A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol. 6(1), e22 (2008).
67. Illingworth RS, Gruenewald-Schneider U, Webb S et al.: Orphan CpG islands identify numerous conserved promoters in the mammalian genome. PLoS Genet. 6(9), e1001134 (2010).
68. Penn NW, Suwalski R, O'Riley C, Bojanowski K, Yura R: The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem. J. 126(4), 781-790 (1972).
69. Kriaucionis S, Heintz N: The nuclear DNA base 5-hydroxymethylcytosine is present in purkinje neurons and the brain. Science 324(5929), 929-930 (2009).
70. Tahiliani M, Koh KP, Shen Y et al.: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929), 930-935 (2009).
71. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC: Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MECP2). Nucleic Acids Res. 32(14), 4100-4108 (2004). (Pubitemid 39232282)
72. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y: Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466(7310), 1129-1133 (2010).
73. Huang Y, Pastor WA, Shen Y, Tahiliani M, Liu DR, Rao A: The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS ONE 5(1), e8888 (2010).
74. Nestor C, Ruzov A, Meehan R, Dunican D: Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques 48(4), 317-319 (2010).
75. Jin SG, Kadam S, Pfeifer GP: Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res. 38(11), e125 (2010).
76. Szwagierczak A, Bultmann S, Schmidt CS, Spada F, Leonhardt H: Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic. Acids Res. 38(19), e181 (2010).
77. Rozen S, Skaletsky HJ: Primer3 on the WWW for general users and for biologist programmers. In:Bioinformatics Methods and Protocols: Methods in Molecular Biology. Krawetz S, Misener S (Eds). Humana Press, Totowa, NJ, USA, 365-386 (2000).